Hepatocellular Carcinoma

Research in hepatocellular carcinoma (HCC) focuses on understanding the development, progression, and treatment of primary liver cancer. Investigations explore the molecular mechanisms underlying HCC, including genetic mutations, epigenetic alterations, and signaling pathways that drive tumor growth and metastasis. Methodologies employed include laboratory-based studies using cell lines and animal models, analysis of patient data, and the application of advanced imaging techniques to identify and characterize tumors. Specific areas of study encompass the role of chronic liver disease, such as viral hepatitis and non-alcoholic fatty liver disease, in HCC development, as well as the evaluation of novel therapeutic strategies, including targeted therapies and immunotherapies.

Given Arkansas's burden of chronic liver disease and associated risk factors, research into HCC is of significant public health importance to the state. Understanding the specific risk profiles and outcomes within Arkansas's population informs targeted prevention and early detection efforts. This work contributes to improving the health and well-being of residents and can potentially reduce healthcare costs associated with advanced liver cancer treatment.

This research area intersects with fields such as liver disease diagnosis and treatment, metabolism and genetic disorders, and viral infections. Expertise in medical imaging, including radiomics and machine learning applications, further enhances diagnostic and prognostic capabilities. Engagement spans multiple institutions within Arkansas, fostering collaborative approaches to addressing this complex disease.